Shire Human Genetic Therapies - MA Middlesex, Lexington 02421

Shire Human Genetic Therapies entered the industry of Biological Research in 1988 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417112, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.

To acquire more information, please contact Richard Seldon, President by calling (617) 349-0200 during business hours. You can also write to the business’ Branch at 300 Shire Way, Lexington, Massachusetts MA 02421. You can also visit the company’s website at tktx.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Shire Human Genetic Therapies
Representative: Richard Seldon, President
Place of Business: 300 Shire Way, Lexington, MA 02421
Contact Number: (617) 349-0200
Website: tktx.com
Type of Service: Biological Research
SIC Number: 8731
NAICS Number: 5417112
Locality: Branch
Market Type: B2B (Business to Business)
Began: 1988
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Shire Human Genetic Therapies is a company operating from Middlesex, Massachusetts providing professional Biological Research and relevant B2B variables. It was founded in 1988 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 5417112 as Biological Research.

With a current employee count of 1 to 4, Shire Human Genetic Therapies has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Richard Seldon, President at (617) 349-0200 for related queries, or to locate its Branch using the coordinates 42.42783,-71.25198.

The Branch can also be found at the street address 300 Shire Way in Lexington, Massachusetts 02421 and can be engaged online through the company website at tktx.com, the company Twitter , and Facebook page .